Search results
Results from the WOW.Com Content Network
Moderna was founded in 2010 by Derrick Rossi, Timothy A. Springer, Kenneth R. Chien, Robert S. Langer, and Noubar Afeyan. [9] Stéphane Bancel, the current CEO, was appointed as CEO in 2011. [6] [10] Between 2011 and 2017, Moderna raised $2 billion in venture capital funding. [7] [8]
A dose of the new Moderna spikevax autumn COVID booster vaccine before it is to be administered at Gorsey Clough Nursing Home, Tottington, Bury, on Thursday, September 8, 2022.
It sees the expansion of the product to younger adults as having a $10 billion total addressable market (TAM). Moderna is also looking to bring 10 new products to market over the next three years.
New, modified versions of Pfizer’s and Moderna’s existing COVID-19 vaccines received a green light from the Food and Drug Administration to be used as booster shots on Wednesday, Aug. 31.
In January 2021, Moderna started development of a new form of its vaccine, called mRNA-1273.351, that could be used as a booster shot against the Beta variant (lineage B.1.351). [ 195 ] [ 186 ] In February 2021, Moderna announced that it had manufactured and shipped sufficient amounts of mRNA-1273.351 to the National Institutes of Health to run ...
All new Pfizer and Moderna vaccines target the Omicron variant KP.2 strain of SARS-CoV-2, the virus that causes COVID. Spikevax, the COVID-19 vaccine manufactured by Moderna and FDA-approved for ...
Moderna is on its way to getting a third mRNA-based vaccine approved by the FDA if the regulatory agency likes the data released Monday for a combination flu-COVID shot.The company said the new ...
Moderna is betting on mRNA technology to do just that. To Fink’s knowledge, none of its competitors has made it to Phase 3 of a clinical trial involving an mRNA norovirus vaccine. View this ...